72 related articles for article (PubMed ID: 2849815)
1. [High dose melphalan and autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung].
Wist E; Kaasa S; Thorud E
Tidsskr Nor Laegeforen; 1988 Sep; 108(27):2271-4. PubMed ID: 2849815
[No Abstract] [Full Text] [Related]
2. High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer.
Wilson C; Pickering D; Stewart S; Vallis K; Kalofonos H; Cross A; Snook D; Goldman JM; McKenzie CG; Epenetos AA
In Vivo; 1988; 2(5):331-4. PubMed ID: 2856521
[TBL] [Abstract][Full Text] [Related]
3. High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer--a negative report.
Littlewood TJ; Bentley DP; Smith AP
Eur J Respir Dis; 1986 May; 68(5):370-4. PubMed ID: 3015650
[TBL] [Abstract][Full Text] [Related]
4. [High-dose chemotherapy with autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung].
Luo KH; Sun Y; Wu GQ
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):306-8. PubMed ID: 1339111
[No Abstract] [Full Text] [Related]
5. Autologous bone marrow transplantation in neoplasia.
Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
[No Abstract] [Full Text] [Related]
6. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
Tomeczko J; Pacuszko T; Napora P; Lange A
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
[No Abstract] [Full Text] [Related]
7. Autologous bone marrow transplantation for the treatment of lung cancer.
Lazarus HM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):72-9. PubMed ID: 8211219
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung.
Glode LM; Robinson WA; Hartmann DW; Klein JJ; Thomas MR; Morton N
Cancer Res; 1982 Oct; 42(10):4270-5. PubMed ID: 6286106
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow and peripheral blood progenitor cell transplants in small cell lung cancer.
Lazarus HM; Elias AD
Bone Marrow Transplant; 1996 Jan; 17(1):1-3. PubMed ID: 8673040
[No Abstract] [Full Text] [Related]
10. [Intensive chemotherapy with bone marrow autograft in solid tumors].
Sculier JP; Stryckmans P; Klastersky J
Rev Med Brux; 1983 Jun; 4(6):409-15. PubMed ID: 6308742
[No Abstract] [Full Text] [Related]
11. Combined-modality therapy and autologous bone marrow transplantation in the treatment of advanced non-Hodgkin's lymphoma and solid tumor: the Kanazawa experience.
Harada M; Yoshida T; Funada H; Ishino C; Kodo H; Mori T; Matsue K; Shiobara S; Odaka K; Ohtake S; Teshima H; Kondo K; Yamamura M; Nakao S; Ueda M; Nakamura S; Hattori K
Transplant Proc; 1982 Dec; 14(4):733-7. PubMed ID: 6301118
[No Abstract] [Full Text] [Related]
12. High dose melphalan with autologous marrow rescue in cancer treatment.
Dewar JM; Forgeson GV; Dady PJ
N Z Med J; 1984 Nov; 97(768):816-8. PubMed ID: 6390271
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT).
Mulder NH; Meinesz AF; Sleijfer DT; Postmus PE; De Vries EG; Van der Geest S; Orie JL; Vriesendorp R
Neth J Med; 1984; 27(10):389-92. PubMed ID: 6096742
[No Abstract] [Full Text] [Related]
14. [Possible role of autotransplantation in small cel bronchial carcinoma].
Tiefengraber E; Sebesta C; Kier P; Ruckser R; Habertheuer KH; Hinterberger W
Wien Med Wochenschr; 1995; 145(2-3):50-2. PubMed ID: 7762253
[TBL] [Abstract][Full Text] [Related]
15. Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Krug LM; Grant SC; Miller VA; Ng KK; Kris MG
Semin Oncol; 1999 Oct; 26(5 Suppl 15):55-61. PubMed ID: 10566613
[TBL] [Abstract][Full Text] [Related]
16. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
Handberg J; Hansen SW
Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells.
Humblet Y; Bosquée L; Weynants P; Symann M
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S36-9. PubMed ID: 8899169
[No Abstract] [Full Text] [Related]
18. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
19. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
20. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
